N-Acetyl Epitalon Amidate

Research Use Only. Not for Human Consumption.

N-Acetyl Epitalon Amidate is supplied by Nexus as a terminally modified Epitalon-style AEDG tetrapeptide analog for controlled in-vitro laboratory research workflows. The supplied research record identifies this material as an N-acetylated, C-terminal amidated analog with the displayed sequence Ac-Ala-Glu-Asp-Gly-NH₂. Available Nexus catalog data lists a single 5mg research size under SKU NET5 in the Cognitive & Nootropic category.

Compound Overview

N-Acetyl Epitalon Amidate is described in the supplied chemistry record as a terminally protected analog of the AEDG Epitalon sequence. The parent sequence is AEDG, while the Nexus display sequence is Ac-Ala-Glu-Asp-Gly-NH₂, indicating an N-terminal acetyl group and a C-terminal amide modification. These terminal modifications distinguish the material from an unmodified AEDG tetrapeptide and make terminal-state confirmation an important part of identity review.

The available source data supports a narrow, chemistry-forward description only. No therapeutic, dosing, human-use, veterinary-use, disease-treatment, or biological outcome claims are included in the supplied record, and Nexus does not infer them here. The compound is presented strictly as an in-vitro research material for qualified laboratory settings.

Research Background & Published Literature

The research dataset identifies N-Acetyl Epitalon Amidate as a terminally protected Epitalon-style analog used in stability and peptide-modification research contexts. The provided source list includes a PubChem record for the parent Epitalon/AEDG sequence and a supplier PDF for N-acetyl Epithalon amidate. The supplied research record does not include peer-reviewed citations specific to this exact terminally modified analog.

Because public catalog entries for this compound are sparse, the computed formula and molecular weight should be treated as provisional until final COA and mass-spectrometry documentation confirm the terminal modifications. This page therefore limits the discussion to the provided structural description, computed chemistry fields, storage guidance, and catalog metadata.

• Parent sequence context: Epitalon-style AEDG tetrapeptide sequence.
• Analog description: N-acetylated, C-terminal amidated AEDG analog.
• Literature limitation: No peer-reviewed citations specific to N-Acetyl Epitalon Amidate were provided in the supplied dataset.
• Verification limitation: Terminal modification state should be confirmed by COA/MS before relying on computed formula values as final release specifications.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Khavinson VKh et al. (2003) — Bull Exp Biol Med
• Khavinson et al. (2017) — Bull Exp Biol Med
• Araj et al. (2025) — Int J Mol Sci

Storage, Handling & Stability Guidelines

Store lyophilized N-Acetyl Epitalon Amidate at -20°C, desiccated, and protected from light. The supplied storage guidance also states that, after reconstitution, laboratories should aliquot the material and avoid repeated freeze-thaw cycles. No validated post-reconstitution stability window, solvent system, or concentration-specific hold time was included in the supplied data.

• Keep lyophilized material sealed, dry, and light-protected during storage.
• Maintain -20°C storage conditions for the unreconstituted material unless a current COA specifies otherwise.
• After reconstitution, divide material into aliquots suitable for the laboratory workflow to reduce repeat freeze-thaw exposure.
• Do not infer a beyond-use date, reconstitution solvent, or working concentration from this page; those parameters are not supplied in the research data.

Lab Verification

Nexus maintains batch-level verification records through the Lab Verified archive. For peptide materials, lab verification may include HPLC review for chromatographic purity and Mass Spectrometry (MS) review for molecular identity. For this specific N-Acetyl Epitalon Amidate record, no exact COA values, purity percentage, batch number, retention time, mass-found value, or test date were provided in the supplied research data.

Because the record flags terminal modification confirmation as a review point, identity verification should specifically confirm the N-acetyl and C-terminal amidate state. Until exact release documentation is available, Nexus should present the computed formula and molecular weight as chemistry-record values rather than finalized batch-specific COA results.